$119.99
GLOW blend, 70mg per vial. 99%+ HPLC purity, third-party tested, dispatched domestically across Australia. Supplied strictly for laboratory research use.
Free Delivery on all orders above $550
21 in stock
Australian Peptides supplies GLOW 70mg as a reference material for laboratory research. Each vial holds 70mg of lyophilised peptide blend. We seal every vial under vacuum and ship from Australian stock. This product is strictly for laboratory use only, and not for human or animal use, consumption, or therapeutic use.
GLOW combines three peptides in a single vial: GHK-Cu, BPC-157 and TB-500. Researchers usually study these three separately, so a blend removes several reconstitution steps and reduces handling loss. However, a blend also fixes the ratio between the components. Therefore GLOW 70mg suits comparative work where that ratio stays constant, and single vials suit work where it does not. We state the exact milligram split for your lot on the certificate of analysis.
An independent laboratory assays every batch at 99% or greater purity by HPLC. In addition, we provide the mass spectrometry report for the current lot on request. Batch numbers appear on the vial label, so you can trace any result back to the matching analysis. Because the blend carries GHK-Cu, the lyophilised powder appears blue rather than white.
Lyophilised peptide stays stable at ambient temperature in transit. However, move it to -20°C on arrival and keep it away from direct light. To reconstitute, add bacteriostatic water. For example, 5mL yields a total peptide concentration of 14mg/mL.
Direct the diluent slowly down the inside wall of the vial rather than onto the powder. Then swirl gently. Never shake the vial, because agitation can shear the peptide chains. Afterwards, hold the vial at 2–8°C, use it within four weeks, and never refreeze it. We stock Bacteriostatic Water 3mL separately.
Each component appears in its own literature. PubMed indexes a review of the GHK-Cu gene data for researchers who want the primary sources. However, researchers have not established efficacy in humans for any component, and we make no therapeutic claims of any kind. Finally, teams often stock the components singly as well, including GHK-Cu 50mg and BPC-157 10mg.
GLOW combines compounds commonly studied together in repair research. Where a protocol also covers metabolic endpoints, our retatrutide range is supplied as R3TA 10mg (retatrutide) and R3TA 20mg (retatrutide). See our retatrutide in Australia guide for pricing, storage and dispatch.
| Weight | 0.0132277 lbs |
|---|---|
| Dimensions | 1 × 1 × 2 in |
Every batch we publish a third-party certificate of analysis. Get told when a new one lands, and when a sold-out peptide is back.
